| Serial Number | 79179556 |
| Word Mark | HUMABODY |
| Filing Date | Wednesday, December 17, 2014 |
| Status | 707 - PARTIAL SECTION 71 ACCEPTED |
| Status Date | Thursday, June 27, 2024 |
| Registration Number | 5158366 |
| Registration Date | Tuesday, March 14, 2017 |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, September 20, 2016 |
| Goods and Services | [ Treatment and transformation of materials for others, namely, the manufacture of chemicals, biologicals, antibodies and antibody fragments; contract manufacturing services in the field of chemicals, biologicals, antibodies and antibody fragments; custom manufacture of therapies using antibodies and antibody fragments ] |
| Goods and Services | pharmaceutical preparations for the treatment of cancer [ , autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases ] ; veterinary preparations for the treatment of cancer [ , autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases ] ; therapeutic pharmaceutical preparations in the nature of antibodies and antibody fragments for medical and veterinary purposes; antibodies being pharmaceutical preparations for the treatment of cancer [ , autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases ] ; antibody fragments being pharmaceutical preparations for the treatment of cancer [ , autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases] ; antibody therapeutics in the nature of therapeutic agents for the treatment of cancer [ , autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases ] ; medical diagnostic reagents and veterinary diagnostic reagents in the nature of antibodies and antibody fragments; antibodies and antibody fragments being therapeutic pharmaceuticals for the treatment of cancer [ , autoimmune diseases, inflammatory conditions, allergies and allergic conditions, hypersensitivity reactions, infections, organ transplant rejection, tissue transplant rejection, cardiovascular diseases, neurological disorders, degenerative disorders, metabolic disorders, dermatological diseases ] and or use in the manufacture of therapeutic products |
| Goods and Services | chemicals used in industry and science; [ chemical test kits for in vitro testing for laboratory research purposes; ] biochemicals, namely, monoclonal antibodies and antibody fragments all being proteins for in vitro scientific and laboratory research use; biochemicals, namely, monoclonal antibodies and antibody fragments for in vitro scientific and laboratory research use; antibodies and antibody fragments all being protein in raw material form for scientific research purposes; antibody reagents used for the detection of antigens in cell and tissue analysis for scientific and laboratory in vitro diagnostic use; antibodies and antibody fragments all being proteins for industrial use in the discovery, preclinical and clinical development of therapeutic products |
| Goods and Services | [ Scientific and technological services, namely, scientific research, analysis and testing and research and design in the field of chemicals, biologicals, antibodies and antibody fragments; Scientific laboratory services in the field of antibodies and antibody fragments; research in the field of the development of antibodies and antibody fragments; provision of scientific information in the field of antibodies and antibody fragments for medical and veterinary purposes; engineering of antibodies and antibody fragments; scientific services, namely, drug discovery, preclinical and clinical development of therapeutic products; consultancy services relating thereto, namely, consulting in the field of antibody and antibody fragment design ] |
| International Class | 040 - Treatment of materials. |
| US Class Codes | 100, 103, 106 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Thursday, June 27, 2024 |
| Primary Code | 040 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry. |
| US Class Codes | 001, 005, 006, 010, 026, 046 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 4, 2016 |
| Primary Code | 001 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, January 4, 2016 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | G - NOT AVAILABLE |
| Class Status Date | Thursday, June 27, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Crescendo Biologics Limited |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 99 - Other |
| Address | Cambridge CB223AT GB |
| Party Name | Crescendo Biologics Limited |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Cambridge CB223AT GB |
| Party Name | Crescendo Biologics Limited |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Cambridge CB223AT GB |
| Event Date | Event Description |
| Tuesday, January 5, 2016 | NON-FINAL ACTION WRITTEN |
| Sunday, January 3, 2016 | SN ASSIGNED FOR SECT 66A APPL FROM IB |
| Monday, January 4, 2016 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, January 4, 2016 | ASSIGNED TO EXAMINER |
| Wednesday, January 6, 2016 | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
| Friday, January 8, 2016 | APPLICATION FILING RECEIPT MAILED |
| Monday, January 11, 2016 | REFUSAL PROCESSED BY MPU |
| Monday, January 11, 2016 | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
| Monday, February 1, 2016 | REFUSAL PROCESSED BY IB |
| Monday, July 11, 2016 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Monday, July 11, 2016 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, July 15, 2016 | ASSIGNED TO LIE |
| Friday, July 15, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, July 15, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, July 29, 2016 | FINAL REFUSAL WRITTEN |
| Friday, July 29, 2016 | FINAL REFUSAL E-MAILED |
| Friday, July 29, 2016 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Monday, August 8, 2016 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, August 8, 2016 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, August 8, 2016 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, August 9, 2016 | EXAMINERS AMENDMENT -WRITTEN |
| Tuesday, August 9, 2016 | EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 9, 2016 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Tuesday, August 9, 2016 | EXAMINER'S AMENDMENT ENTERED |
| Tuesday, August 9, 2016 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, August 17, 2016 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, August 31, 2016 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Wednesday, August 31, 2016 | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
| Wednesday, August 31, 2016 | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
| Tuesday, September 20, 2016 | PUBLISHED FOR OPPOSITION |
| Tuesday, September 20, 2016 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, October 18, 2016 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Friday, November 18, 2016 | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
| Friday, February 3, 2017 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Tuesday, March 14, 2017 | REGISTERED-PRINCIPAL REGISTER |
| Friday, July 14, 2017 | FINAL DECISION TRANSACTION PROCESSED BY IB |
| Wednesday, June 14, 2017 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
| Thursday, June 22, 2017 | FINAL DISPOSITION PROCESSED |
| Thursday, June 22, 2017 | FINAL DISPOSITION NOTICE SENT TO IB |
| Thursday, December 7, 2017 | NEW REPRESENTATIVE AT IB RECEIVED |
| Monday, March 14, 2022 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
| Saturday, August 19, 2023 | RESTRICTION OF HOLDER'S RIGHT OF DISPOSAL RECEIVED |
| Wednesday, September 13, 2023 | TEAS SECTION 71 RECEIVED |
| Tuesday, May 7, 2024 | CASE ASSIGNED TO POST REGISTRATION PARALEGAL |
| Friday, October 27, 2023 | LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED |
| Thursday, June 27, 2024 | REGISTERED - PARTIAL SEC 71 ACCEPTED |
| Thursday, June 27, 2024 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED |